ISSN: 1359-6101

Journal Home

Journal Guideline

Cytokine and Growth Factor Reviews Q1 Unclaimed

Elsevier BV United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cytokine and Growth Factor Reviews is a journal indexed in SJR in Biochemistry, Genetics and Molecular Biology (miscellaneous) and Immunology with an H index of 152. It has an SJR impact factor of 2,432 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1) Endocrinology, Diabetes and Metabolism (Q1) Immunology (Q1) Immunology and Allergy (Q1) Immunology and Allergy (Q1)

Price

- €

Gold OA

-

Green OA

- €

Non OA

Metrics

2,432

SJR Impact factor

152

H Index

43

Total Docs (Last Year)

178

Total Docs (3 years)

5313

Total Refs

1118

Total Cites (3 years)

172

Citable Docs (3 years)

6,06

Cites/Doc (2 years)

123,56

Ref/Doc

Aims and Scope

Other journals with similar parameters

Nature Protocols Q1
Molecular Systems Biology Q1
EMBO Journal Q1
Annals of the Rheumatic Diseases Q1
eLife Q1

Best articles

Bone morphogenetic proteins in craniofacial and periodontal tissue engineering: Experimental studies in the non-human primate Papio ursinus

Can cord blood cells support the cytokine storm in GvHD?

CD100/Sema4D, a lymphocyte semaphorin involved in the regulation of humoral and cellular immune responses

Chemokines and tuberculosis

Chemokines provide the sustained inflammatory bridge between innate and acquired immunity

Cytokine and Growth Factor Reviews to be published six times a year

Cytokines revisited at Hilton Head

Dimerization of chemokine receptors and its functional consequences

Dual role of tumor necrosis factor alpha in brain injury

Erratum to "Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors" [Cytokine & Growth Factor Reviews 12(2/3) 219-243]

Erratum to "Silencing STATs: lessons from paramyxovirus interferon evasion"

Evaluating the potential of IL-27 as a novel therapeutic agent in HIV-1 infection

SHOW MORE ARTICLES

Folate-targeted immunotherapies: Passive and active strategies for cancer

Forty years of interferon, forty years of cytokines

HIV chemokine receptor inhibitors as novel anti-HIV drugs

IL-10 family of cytokines

IL-12 and Viral Infections

Immune checkpoint therapy of mesothelioma: Pre-clinical bases and clinical evidences

Infection and cancer: the common vein

Insight into interleukin-37: The potential therapeutic target in allergic diseases

Insulin-like growth factor binding proteins and angiogenesis: from cancer to cardiovascular disease

Interaction of chemokines and glycosaminoglycans: A new twist in the regulation of chemokine function with opportunities for therapeutic intervention

Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease

Interleukin-21: A new modulator of immunity, infection, and cancer

Comments

No comments ... Be the first to comment!

Publication speed

Review quality

Edition and editorial team

Paper Link

Attach one of your papers. We need to confirm that you have had a relation with this journal in order to review its service.